Company intelligence / Profile preview

ADAR1 Capital Management

Austin, Texas, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

ADAR1 Capital Management is an SEC-registered investment manager based in Austin, Texas. Founded in October 2018 by Dr. Daniel Schneeberger, the firm specializes in public and private equity investments within the life sciences and biotechnology sectors. It is known for its activist approach with significant holdings such as Keros Therapeutics (KROS), where it has advocated for strategic changes[1][6][8]. The team brings deep medical, scientific, and financial expertise to biopharma investing[1][8].

Industry: Investors

Partnerships

Co-investment partnerships with other healthcare/life science investors through syndicate deals (e.g., Affinity Healthcare, Ally Bridge Group)

Beyond the preview

Go deeper on ADAR1 Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADAR1 Capital Management.

Explore the full profile